What does EyePoint Pharmaceuticals, Inc. do?

Jun 22 2025 06:31 PM IST
share
Share Via
EyePoint Pharmaceuticals, Inc. develops drug delivery products for chronic eye diseases and has a market cap of $606.23 million. As of March 2025, it reported net sales of $24 million and a net loss of $45 million.
Overview:
EyePoint Pharmaceuticals, Inc. develops drug delivery products primarily for the treatment of chronic eye diseases and operates within the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company. Financial Snapshot: Most recent Net Sales: 24 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -45 Million (Quarterly Results - Mar 2025) Market-cap: USD 606.23 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -1.06 Return on Equity: -49.19% Price to Book: 2.03 Contact Details: Address: 480 Pleasant St Ste B300, WATERTOWN MA: 02472-2468 Tel: ['1 617 9265000', '1 617 3406075'] Fax: 1 617 9265050 Website: https://eyepointpharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News